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sucrose diluted in PBS containing 5% BSA. When the solution appeared homogeneous, it
was spun for 5 min at 500g. Supernatants (30 ml) were inoculated i.c. into groups of four
tga20 mice19. Infectivity titres were then determined using the relationship
y ¼ 11.45 2 0.088x (y, log LD50 per millilitre of homogenate; x, incubation time in days to
terminal disease), which was derived by linear regression using Prusiner’s method17.
Western blot analysis
Tissue homogenates were adjusted to 5 mg ml21 protein and run natively or after
treatment with proteinase K (50 mg ml21, 30 min, 37 8C). 50 mg of total protein were
electrophoresed through 12% SDS–PAGE and blotted. Membranes were incubated with
monoclonal antibody ICSM18 to PrP (1:20,000)27 or TH-2 to tyrosine hydroxylase
(1:5,000; Sigma), and visualized by enhanced chemiluminescence (ECL; Amersham).
Histology and immunohistochemistry
Paraffin (2 mm) and frozen sections from brain (10 mm) or spleen (5 mm) were stained with
haematoxylin/eosin. Immunostaining for glial fibrillary acidic protein (GFAP) was
performed with a rabbit antiserum (1:300 dilution; DAKO) and detected with biotinylated
swine anti-rabbit serum (1:250 dilution; DAKO) and diaminobenzidine (Sigma).
Antibodies FDC-M1 (clone 4C11; 1:50; Becton Dickinson), CD35 (8C12; Pharmingen)
and anti-CD45RO/B220 (RA3-6B2; Pharmingen) were used as described28. For the
assessment of splenic innervation, floating sections were blocked in 4% goat serum,
incubated overnight with a polyclonal anti-TH antibody (1:400; Fluka), washed, and
incubated with a biotinylated secondary antibody (1:100 goat anti rabbit; Vector).
Visualization was accomplished with nickel-enhanced diaminobenzidine. Morphometric
analysis was performed using Analysis Pro 3.1 software (Soft Imaging System; Münster).
FDCs were quantified by measuring the FDC-M1þ surface in $48 WT and CXCR52/2
follicles. For LTbR-Fc and human-IgG-treated mice, $12 follicles were examined.
Treatment with LTbR fusion protein
Mice were treated i.p. with 250 mg LTbR-Ig fusion protein29 one week before prion
inoculation. Injection was repeated 14 and 28 days later. For control, Sv129 mice were
subjected to the same regimen with 250 mg of a human IgG polyclonal preparation
(Biogen) instead of LTbR-Ig. Two mice from each group were analysed for prion
infectivity and PrPSc content 38 days after inoculation.
Bone marrow chimaeric mice
5 £ 106 bone marrow cells were isolated from tibiae and femurs, and injected into tail veins
of 8–10-week-old recipients conditioned by whole-body irradiation (1,100 rad) 24 h
earlier. 6–8 weeks after grafting, reconstitution was assessed by FACS analysis of peripheral
blood taken from the retro-orbital plexus of ether-anaesthetized mice. Blood samples were
prepared at 4 8C in buffer solution (PBS containing 2% FCS and 0.2% NaN3) and stained
with fluorescein isothiocyanate (FITC)-labelled CD45R/B220 (Pharmingen) and
phycoerythrin (PE)-labelled anti-CXCR5 (clone 2G8; ref. 13). After lysis of erythrocytes
with FACS lysis solution (Becton Dickinson) and washing, cell suspensions were analysed
with a FACSCalibur (Becton Dickinson). Viable cells were gated by forward and side light
scatter. Data were acquired with CellQuest software (Becton Dickinson). The following
markers were used: anti-B220-PerCP, anti-CD21-FITC, anti-CD23-bio, anti-CD23-PE,
anti-CD18-PE, anti-CD29-biotin, anti-CD49d-biotin, anti-CD5-bio, anti-CD11b
(Mac-1)-FITC, anti-CD11a-biotin and streptavidin-APC (all from BD-Pharmingen). For
characterization of marginal zone-B (MZB) and follicular B (FB) cells, a combination of
anti-B220/CD21/CD23 was used. For detection of integrin expression on MZB cells, anti-
CD49d (anti-a4), anti-CD11a (anti-aLb2), anti-CD18 (anti-b2) and anti-CD29 (anti-b1)
antibodies were combined with the anti-B220/CD21/CD23 stain. For identification of
peritoneal B-1 and B-2 cells, a combination of anti-B220/CD5/CD11b antibodies was
used.
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Stem cells persist throughout life by self-renewing in numerous
tissues including the central1 and peripheral2 nervous systems.
This raises the issue of whether there is a conserved mechanism
to effect self-renewing divisions. Deficiency in the polycomb
family transcriptional repressor Bmi-1 leads to progressive post-
natal growth retardation and neurological defects3. Here we show
that Bmi-1 is required for the self-renewal of stem cells in the
peripheral and central nervous systems but not for their survival
or differentiation. The reduced self-renewal of Bmi-1-deficient
neural stem cells leads to their postnatal depletion. In the absence
of Bmi-1, the cyclin-dependent kinase inhibitor gene p16 Ink4a is
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upregulated in neural stem cells, reducing the rate of prolifera-
tion. p16 Ink4a deficiency partially reverses the self-renewal defect
in Bmi-12/2 neural stem cells. This conserved requirement for
Bmi-1 to promote self-renewal and to repress p16 Ink4a expression
suggests that a common mechanism regulates the self-renewal
and postnatal persistence of diverse types of stem cell. Restricted
neural progenitors from the gut and forebrain proliferate nor-
mally in the absence of Bmi-1. Thus, Bmi-1 dependence dis-
tinguishes stem cell self-renewal from restricted progenitor
proliferation in these tissues.
Bmi-1 is an oncogene that causes neoplastic proliferation when
overexpressed in lymphocytes4,5. Deletion of Bmi-1 leads to defects
in axial skeleton patterning and haematopoiesis, and to ataxia
and seizures3. Bmi-1-deficient mice can survive into adulthood
but show progressive postnatal growth retardation (ref. 3 and
Supplementary Fig. 1), raising the possibility that Bmi-1 regulates
stem cell function. Two studies have shown that Bmi-1 is required
for the postnatal maintenance of haematopoietic stem cells6,7. In
those studies, however, it was not technically possible in the
haematopoietic system to discern directly whether the failure of
stem cell maintenance was caused by a defect in self-renewal or
survival.
To determine whether Bmi-1 regulates the self-renewal of mouse
neural stem cells, we examined the effect of Bmi-1 deficiency on the
self-renewal of central nervous system (CNS) stem cells from the
telencephalon at embryonic day 14.5 (E14.5)8 and neural crest stem
cells (NCSCs) from the gut at E14.5 (enteric nervous system)9. CNS
stem cells form CNS neurospheres, whereas gut NCSCs form PNS
neurospheres in non-adherent cultures (Fig. 1 and Supplementary
Fig. 3). CNS and PNS neurospheres and purified uncultured
p75þa4
þ rat gut NCSCs9 expressed Bmi-1 (Supplementary Fig. 2
and data not shown). Bmi-12/2 telencephalon cells formed multi-
potent neurospheres, but at a significantly lower frequency
(P , 0.05) than did wild-type telencephalon cells (Fig. 1). This
suggests that there are significantly fewer stem cells in the Bmi-12/2
telencephalon. The Bmi-12/2 neurospheres were also roughly
14-fold smaller in volume (P , 0.01) and gave rise to 33-fold
fewer (P , 0.01) secondary neurospheres on subcloning, indicating
a defect in self-renewal. In the E14.5 PNS, the frequency of cells
capable of forming neurospheres did not differ between wild-type
and Bmi-12/2 guts, but the Bmi-12/2 neurospheres were signifi-
cantly smaller and gave rise to 60-fold fewer secondary multipotent
neurospheres (P , 0.01) on subcloning (Fig. 1). Thus, Bmi-1
deficiency reduced the self-renewal of both CNS stem cells and
NCSCs in culture.
If neural stem cells require Bmi-1 for normal self-renewal in vivo,
the stem cells in Bmi-1-deficient mice should become depleted
postnatally. In the absence of Bmi-1, the frequency of lateral
Figure 1 CNS stem cells and gut neural crest stem cells (NCSCs) require Bmi-1 to self-
renew normally. Images show typical neurospheres that formed after 10 d in non-
adherent cultures from E14.5 CNS neural stem cells (a) or PNS NCSCs (b). a, The
frequency of Bmi-1 2/2 E14 telencephalon cells, P0 SVZ cells or P30 SVZ cells that
formed multipotent CNS neurospheres was significantly reduced relative to wild-type cells
(*P , 0.05). The diameter and self-renewal of the Bmi-1 2/2 neurospheres were also
significantly reduced. Self-renewal capacity is expressed as the number of secondary
neurospheres generated per primary neurosphere on subcloning. b, Similar results were
obtained for multipotent PNS neurospheres generated by E14.5, P0 or P30 wild-type and
Bmi-1 2/2 gut cells, except that the frequency of neurosphere-forming cells was not
significantly reduced until P30. Values are the mean ^ s.d. for 3–6 independent
experiments. Bmi-1 deficiency also consistently reduced self-renewal when the data were
normalized to control for differences in the size of neurospheres: 3.5 ^ 0.8% of
dissociated wild-type P0 PNS neurosphere cells formed secondary neurospheres on
subcloning, as compared with 0.3 ^ 0.1% of Bmi-1 2/2 cells (P , 0.001). ND, not
determined.
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ventricle subventricular zone (SVZ) cells and gut cells that were
capable of forming multipotent neurospheres in culture was mod-
estly reduced at postnatal day 0 (P0) and strongly reduced at P30
(Fig. 1). Similar trends were observed in terms of the ability of the
cells to form multilineage adherent colonies in culture (data not
shown). The extent to which Bmi-1 deficiency reduced the self-
renewal potential of stem cells increased over time (Fig. 1). Thus,
Bmi-1 is required for the self-renewal of stem cells in diverse tissues,
and Bmi-12/2 stem cells rarely persist into adulthood.
Consistent with the reduction in neurosphere size (Fig. 1),
Bmi-12/2 neural stem cell colonies contained one-third to one-
tenth as many cells as did wild-type colonies (Fig. 2a). We were
unable to detect any increase in cell death in Bmi-12/2 stem cell
colonies or in the SVZ of the lateral ventricle in vivo (Fig. 2b–d). By
contrast, the proliferation of cells in stem cell colonies was signifi-
cantly reduced (Fig. 2e, f). Thus, the reduced self-renewal of
Bmi-12/2 neural stem cells was caused at least partly by reduced
proliferation.
To assess the effect of Bmi-1 on proliferation in vivo, we examined
the rate of 5-bromodeoxyuridine (BrdU) incorporation into P0 and
P30 SVZ cells. As compared with wild-type SVZ cells, Bmi-12/2
SVZ cells showed a significantly lower rate of BrdU incorporation at
both ages (17.8 ^ 0.5% (Bmi-12/2) versus 19.9 ^ 2.0% (wild
type) of SVZ cells were BrdU-positive at P0; P , 0.05), although
the effect was greater at P30 (13.1 ^ 2.7% versus 20.1 ^ 0.5%;
P , 0.01).
Bmi-1 deficiency is associated with increased expression of the
p16 Ink4a and p19Arf genes encoding cyclin-dependent kinase inhibi-
tors, and deletion of these genes partially rescues the growth of
Bmi-12/2 mice10–12. Analysis by quantitative real-time polymerase
chain reaction (qRT–PCR) showed that p16 Ink4a expression
increased 5–21-fold, whereas p19 Arf expression increased 1.4–3-
fold, in Bmi-12/2 CNS and PNS neurospheres of all ages (Sup-
plementary Table 1 and Supplementary Figs 4f and 5f). To test
whether p16 Ink4a regulates neural stem cell self-renewal, we exam-
ined neurospheres cultured from p162/2 adult mice (ref. 13 and
Fig. 3). p162/2 neurospheres from both the CNS and PNS were
larger and self-renewed to a significantly greater extent than did
wild-type neurospheres (Fig. 3a, b). Adherent CNS and PNS p162/2
stem cell colonies contained more cells and incorporated BrdU at a
higher rate (Fig. 3c–f). These data indicate that p16 Ink4a inhibits
neural stem cell self-renewal in culture, although the magnitude of
this effect may depend on culture conditions, because p16 Ink4a can
be induced in response to stress14.
To address directly whether Bmi-1 promotes neural stem cell self-
renewal by suppressing the expression of p16 Ink4a, we generated
Bmi-12/2p162/2 mice. p16 Ink4a deficiency significantly increased
the self-renewal of Bmi-12/2 CNS stem cells and NCSCs in culture
(P , 0.01), but did not fully restore self-renewal to wild-type levels
(Fig. 3g, h). This indicates that there are additional pathways
downstream of Bmi-1 that regulate self-renewal, perhaps including
p19 Arf. The increased self-renewal of Bmi-12/2p162/2 CNS stem
cells and NCSCs was associated with a significant increase in the
rate of proliferation in stem cell colonies (23.5 ^ 11.1% BrdU-
Figure 2 Bmi-1 deficiency reduces proliferation but does not increase cell death in CNS
stem cell colonies. P0 SVZ cells were dissociated and plated in adherent cultures, and the
number of cells per colony was counted after 4, 7 and 14 d (a). All colonies were counted
after 4 d, but only colonies that contained neurons and glia were counted after 7 and 14 d.
At all time points, wild-type (WT) colonies contained significantly more cells than the
Bmi-1 2/2 colonies (*P , 0.01). Similar results were obtained at E14 and P30 (not
shown). Only a few cells in adherent CNS stem cell colonies (b) or in the P0 SVZ (c) stained
with antibodies against activated caspase-3 (a marker of cell death). Arrows and
arrowheads indicate the SVZ and caspase-3-positive cells, respectively. Note that the
choroid plexus in the lateral ventricle is highly autofluorescent (c). No statistically
significant difference in the frequency of dying cells was observed between wild-type and
Bmi-1 2/2 CNS stem cell colonies on the basis of the frequency of condensed,
fragmented nuclei identified by 4
0
,6-diamidino-2-phenylindole dihydrochloride (DAPI)
staining (d), or activated caspase-3 (not shown). Bmi-1 deficiency was associated with a
significant decrease in the rate of BrdU incorporation into CNS stem cell colonies
(e, f; *P , 0.01), indicating reduced proliferation. A similar reduction in proliferation was
observed in Bmi-1 2/2 NCSC colonies in culture (not shown).
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positive cells versus 8.9 ^ 11.6% in Bmi-12/2p16þ/þ CNS stem-
cell colonies, P , 0.01). Therefore, the increase in p16 Ink4a
expression in the absence of Bmi-1 contributed to the reduced
self-renewal of Bmi-12/2 neural stem cells in culture.
Because p16 Ink4a and p19 Arf expression can increase in cultured
cells15, we examined whether these genes were also upregulated in
uncultured progenitors (Supplementary Table 1). Expression of
p16 Ink4a RNA and protein was increased in the P0 and P30 SVZ of
Bmi-12/2 mice but was not detected in the E15 telencephalon
(Supplementary Table 1 and Supplementary Fig. 4e). p16 Ink4a
was also upregulated in uncultured Bmi-12/2 P30 SVZ FSChiS-
SEA-1hiCD242/lo cells, which are enriched for CNS stem cells16,17.
Expression of p19 Arf followed similar trends but was upregulated to
a lesser extent than p16 Ink4a (Supplementary Table 1). In the PNS,
p16 Ink4a and p19 Arf followed trends similar to those observed in the
CNS. Expression of p16 Ink4a was also increased in P0 and P30
uncultured Bmi-12/2 p75þ gut cells, which are enriched for
NCSCs2. Consistent with the increased expression of p16Ink4a in
the nervous system of Bmi-1-deficient mice in vivo, p16 deficiency
partially rescued at least some aspects of nervous system develop-
ment in Bmi-12/2 mice. For example, the number of neurons per
section through the P30 distal small intestine was 92 ^ 30 (mean ^
s.d.) for wild-type, 47 ^ 19 for Bmi-12/2 and 78 ^ 18 for Bmi-12/2
p162/2 mice (all differences P , 0.05).
These data suggest that Bmi-1 is required in the nervous system in
vivo to repress p16Ink4a and p19 Arf postnatally but not during fetal
development. The lack of p16 Ink4a or p19 Arf expression in the
Bmi-12/2 telencephalon may be a reason why forebrain develop-
ment seems relatively normal in Bmi-12/2 newborns despite the
poor proliferation of E14.5 Bmi-12/2 neurospheres, which do
express p16 Ink4a in culture. Nonetheless, p16 Ink4a expression was
increased in vivo in the Bmi-12/2 SVZ at P0 and P30, consistent
with the proliferation defect observed in the postnatal SVZ and with
the postnatal depletion of stem cells.
Figure 3 p16 Ink4a negatively regulates the self-renewal of CNS stem cells and gut NCSCs
in culture. SVZ and gut cells from adult p16 2/2 and wild-type mice were dissociated and
cultured to generate neurospheres (a, b) or adherent stem cell colonies (c–f). After 7 d
(a, c, e) or 10 d (b, d, f) in culture, self-renewal (a, b), the total number of cells per colony
(c, d), and the percentage of BrdU-positive cells per colony (e, f) were assayed. In each
case, the p16 2/2 adult neural stem cell colonies self-renewed more, proliferated more
and contained more cells (*P , 0.05). No differences were observed between p16 2/2
and wild-type colonies in the frequency of apoptotic cells (0.59 ^ 0.61% versus
0.35 ^ 0.48% respectively). Bmi-1 þ/2p16 þ/2 mice were also bred to generate P0
pups, from which SVZ CNS stem cells (g) and gut NCSCs (h) were cultured. For both types
of cell, p16 Ink4a deficiency significantly increased the self-renewal of Bmi-1 2/2 stem
cells (*P , 0.01), although it did not fully restore self-renewal to wild-type levels
(*P , 0.01 relative to wild type). Note that p16 Ink4a deficiency in Bmi-1 þ/þ stem cells
significantly increased the self-renewal of P0 NCSCs (h) but not P0 CNS stem cells (g).
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The proliferation of restricted neural progenitors might be
regulated differently from that of stem cells because restricted
progenitors are not multipotent and divide a limited number of
times before becoming postmitotic. To test whether these cells are
dependent on Bmi-1, we cultured E14 telencephalon cells, or P0 or
P30 SVZ cells, at clonal density under adherent conditions. In
contrast to the significantly reduced frequency of stem cells in
Bmi-12/2 samples (Fig. 1), the frequency of cells that formed
neuron-only or glia-only colonies did not significantly differ
between wild-type and Bmi-12/2 samples (Fig. 4a). There were
also no significant differences in the number of cells per neuron-
only or glia-only colony from the CNS or PNS (Fig 4b–e). Thus,
Bmi-12/2 restricted neural progenitors were present in relatively
normal numbers and proliferated normally in culture.
To test whether lineage commitment caused the proliferation of
neural progenitors to become Bmi-1 independent, we cultured E14
gut p75þ neural crest cells at clonal density for 4 d with or without
bone morphogenetic protein 4 (BMP4), which instructs gut NCSCs
to undergo neurogenesis9,18,19. In the absence of BMP4 no neuron-
only colonies were observed in these cultures, but in the presence of
BMP4 significant numbers of neuron-only colonies emerged. The
number of cells per neuron-only colony did not differ between wild-
type and Bmi-12/2 cultures (Fig. 4e).
Neuregulin (Nrg) promotes the proliferation of glial progenitors
in addition to instructing postnatal gut NCSCs to acquire a glial
fate2,19,20. To test whether Bmi-12/2 glial progenitors proliferated
normally when stimulated by Nrg, we cultured dissociated P0 gut
cells in adherent cultures at clonal density with or without Nrg for
6 d. In the absence of Nrg, Bmi-12/2 colonies incorporated BrdU
(pulsed on day 6) at only a third of the rate of wild-type colonies;
however, in the presence of Nrg, Bmi-12/2 colonies incorporated
BrdU at almost the same rate as wild-type colonies (Fig. 4f). These
data indicate that lineage determination factors change the cell-
cycle regulation of stem cells in addition to restricting their develop-
mental potential, causing the proliferation of neural progenitors to
become Bmi-1 independent.
Bmi-1 was expressed in restricted neural progenitors and p16 Ink4a
RNA and protein expression remained increased in Bmi-12/2
restricted neural progenitor colonies (Supplementary Fig. 5f);
however, p16 Ink4a deficiency did not affect the frequency or pro-
liferation of restricted neural progenitors (Supplementary Fig. 5).
Thus, lineage restriction was associated with a change in cell-cycle
regulation that caused restricted neural progenitors to proliferate in
culture in a way that was not affected by Bmi-1 or p16 Ink4a
deficiency.
The reduced stem cell frequency in the Bmi-12/2 telencephalon
(Fig. 1) indicates that other pathways downstream of Bmi-1 may
also regulate self-renewal, because neither p16 Ink4a nor p19 Arf was
Figure 4 Restricted neural progenitors from the CNS and PNS proliferate normally in the
absence of Bmi-1. E14 telencephalon cells or P0 or P30 SVZ cells were dissociated and
cultured at clonal density under adherent conditions. a–c, The frequency of CNS cells that
formed neuron-only or glia-only colonies after 12–14 d in culture did not significantly
differ between wild-type (WT) and Bmi-1 2/2 mice (a), nor did the number of cells per
neuron-only colony (b) or glia-only colony (c). d, The number of cells per glia-only colony
formed by dissociated P0 gut cells did not differ between wild-type and Bmi-1 2/2 mice.
e, In BMP4-treated cultures of E14.5 gut p75þ cells, no difference was observed in the
number of cells per neuron-only colony. f, Bmi-1 2/2 neural progenitor colonies in the
absence of Nrg proliferated at a significantly lower rate than did wild-type colonies
(*P , 0.01), but Bmi-1 2/2 colonies in the presence of Nrg proliferated similarly to wild-
type colonies (although the difference was still statistically significant, *P , 0.05).
letters to nature
NATURE | VOL 425 | 30 OCTOBER 2003 | www.nature.com/nature966 © 2003 Nature Publishing Group
expressed in the telencephalon (Supplementary Table 1). To identify
additional pathways that are regulated directly or indirectly by
Bmi-1, we compared the gene expression profiles of wild-type and
Bmi-12/2 neurospheres that had been cultured from the P0 SVZ or
from the P0 gut. Because Bmi-1 is a repressor21,22, and the function
of Bmi-1 seems to be conserved between CNS and PNS stem cells,
we examined whether any genes were significantly upregulated (fold
change .2; P , 0.05) in Bmi-12/2 neurospheres from both the
CNS and PNS. We found 11 genes that met these criteria and that
were confirmed to be expressed differentially in independent
samples by qRT–PCR (out of 36,701 probe sets examined; Sup-
plementary Table 2). In addition to p16 Ink4a and p19 Arf, these
included genes that were previously identified as being regulated
by Bmi-1, such as Hox genes (hoxD8, hoxD9 and hoxC9)7,23,24, and
several genes that have not been previously identified as being
regulated by Bmi-1, such as the cyclin-dependent kinase inhibitor
gene p21, which regulates haematopoietic stem cell self-renewal25,
and Gas6, which encodes a ligand for the Axl receptor tyrosine
kinase26. More work will be required to determine whether any of
these genes regulate neural stem cell self-renewal.
Although Bmi-1 was found to be consistently required for the
self-renewal of haematopoietic stem cells6,7, CNS stem cells and
NCSCs, it was not required for the proliferation of restricted
neuronal and glial progenitors from the forebrain or from the
enteric nervous system (Fig. 4). It is not the case that all restricted
progenitors proliferate normally in the absence of Bmi-1, because
Bmi-12/2 lymphocytes are also impaired in their proliferation3. It is
also possible that other types of restricted neural progenitor (such as
from other regions of the nervous system) might require Bmi-1 for
proliferation as the intrinsic properties of neural progenitors vary
among regions of the nervous system9. Nonetheless, Bmi-1 depen-
dence distinguishes stem cell self-renewal from the proliferation of
at least some types of restricted progenitor, providing insight that
will help to elucidate these pathways further. A
Methods
Isolation of CNS and PNS progenitors
Bmi-1þ/2 mice that had been backcrossed at least six times onto a C57BL/6 background
were mated to generate E14.5 embryos, P0 pups, or 4–5-week-old adults that were
genotyped by PCR (see Supplementary Information). p162/2 mice were on an FVB
background and were also genotyped by PCR. For CNS preparations, we dissected
embryonic telencephalons or P0 or P30 SVZs as described16,27. CNS progenitors were
dissociated and plated as described in the Supplementary Information. We processed
embryonic gut tissues as described9. Dissociated embryonic gut cells were stained with an
antibody against p75 (Chemicon International), and p75þ cells (which include NCSCs)
were sorted by a FACSVantage dual-laser flow cytometer (Becton-Dickinson) into culture
plates. Guts from P0 and P30 mice were dissected in ice-cold PBS, and the outer muscle/
plexus layers were peeled free from the underlying epithelium as described2, dissociated
and plated by pipette.
Cell culture
Cell suspensions were plated on adherent plates at clonal density, which means that cells
were plated at a low density such that individual cells could form spatially distinct
colonies19. This allowed us to infer the developmental and proliferative potential of single
cells on the basis of the types and numbers of cells that comprised each colony. For
proliferation studies, 10 mM BrdU was added to the cultures for 1 h at 37 8C before the cells
were fixed and stained with an antibody against BrdU. Culture conditions are described in
the Supplementary Information.
For the neurosphere formation assays (non-adherent cultures) we used ultra-low
binding plates (Corning). To test the self-renewal capacity of the neurospheres, individual
CNS neurospheres were selected, centrifuged at 210g for 4 min, and then mechanically
dissociated and replated. PNS neurospheres were plated for 24 h into plates treated with
poly-D-lysine, and then trypsin-digested, mechanically dissociated, and replated. We
quantified self-renewal as the number of secondary neurospheres generated per primary
neurosphere (28NS/18NS).
Tissue fixation and immunohistochemistry
Mice were injected intraperitoneally with 50 mg per kg (body weight) BrdU and killed
after 2 h for perinatal mice and after 3 h for adult mice. The brains were fixed immediately
in 4% paraformaldehyde and immunostained as described in the Supplementary
Information.
The methods used for qRT–PCR, western blot analysis and microarray analysis are
described in the Supplementary Information.
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